121 related articles for article (PubMed ID: 32612806)
1. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
F1000Res; 2019; 8():613. PubMed ID: 32612806
[No Abstract] [Full Text] [Related]
2. Mutation Profiling of Intracranial Myxopapillary Ependymoma by Next Generation DNA Sequencing.
Taher MM; Alhussini AA; Saeed M; Athar M; Bantan NAA; Jastania RA; Balkhoyour KB; Nageeti TH
Gulf J Oncolog; 2021 Sep; 1(37):7-16. PubMed ID: 35152189
[TBL] [Abstract][Full Text] [Related]
3. Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing.
Taher MM; Bantan NA; Alwalily MH; Saeed M; Taher NM; Bouzidi M; Jastania RA; Balkhoyour KB
Cureus; 2023 Jun; 15(6):e39818. PubMed ID: 37273678
[TBL] [Abstract][Full Text] [Related]
4. Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis.
Jastania RA; Saeed M; Al-Khalidi H; AlQuthami K; Nageeti TH; Al-Allaf FA; Valerie K; Taher MM
Int Med Case Rep J; 2020; 13():123-137. PubMed ID: 32368160
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation DNA Sequencing of Grade 1 Meningioma Tumours: A Case Report of Angiomatous and Psammomatous Meningiomas.
Taher MM; Ashour KM; Althaqafi BA; Mansouri A; Al-Harbi AA; Filfilan W; Bakhsh GY; Bantan NA; Saeed M; AlQuthami K
Cureus; 2024 Feb; 16(2):e54009. PubMed ID: 38476782
[TBL] [Abstract][Full Text] [Related]
6. Identification of PKHD1 mutations in Brain, Breast and Rectal tumors by Next Generation DNA Sequencing.
Mohammed Almehmadi D; Saleh Dairi A; Ali Hassan A; Dannoun A; Saleh Banni H; M Melibary E; Youssef AR; M Taher M
Gulf J Oncolog; 2021 Jan; 1(35):42-53. PubMed ID: 33716212
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
Kanagal-Shamanna R; Portier BP; Singh RR; Routbort MJ; Aldape KD; Handal BA; Rahimi H; Reddy NG; Barkoh BA; Mishra BM; Paladugu AV; Manekia JH; Kalhor N; Chowdhuri SR; Staerkel GA; Medeiros LJ; Luthra R; Patel KP
Mod Pathol; 2014 Feb; 27(2):314-27. PubMed ID: 23907151
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
Pepe F; Pisapia P; Del Basso de Caro ML; Conticelli F; Malapelle U; Troncone G; Martinez JC
Histol Histopathol; 2020 Jul; 35(7):741-749. PubMed ID: 31872418
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
10.
Pujadas E; Chen L; Weingart JD; Orr B; Ozer BH; Holdhoff M; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):179-187. PubMed ID: 32017698
[TBL] [Abstract][Full Text] [Related]
11. EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma.
Taher MM; Dairi G; Butt EM; Al-Quthami K; Al-Khalidi H; Jastania RA; Nageeti TH; Bogari NM; Athar M; Al-Allaf FA; Valerie K
Oncol Lett; 2020 Dec; 20(6):384. PubMed ID: 33193845
[TBL] [Abstract][Full Text] [Related]
12. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
[TBL] [Abstract][Full Text] [Related]
13. Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.
Jauhri M; Bhatnagar A; Gupta S; Shokeen Y; Minhas S; Aggarwal S
Med Oncol; 2016 Oct; 33(10):106. PubMed ID: 27568332
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of serous ovarian carcinoma using a multigene next generation sequencing cancer panel approach.
Ab Mutalib NS; Syafruddin SE; Md Zain RR; Mohd Dali AZ; Mohd Yunos RI; Saidin S; Jamal R; Mokhtar NM
BMC Res Notes; 2014 Nov; 7():805. PubMed ID: 25404506
[TBL] [Abstract][Full Text] [Related]
16. Novel fusion genes and chimeric transcripts in ependymal tumors.
Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
[TBL] [Abstract][Full Text] [Related]
17. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma.
Zang D; Dong Z; Liu Y; Chen Q
BMC Neurol; 2024 Feb; 24(1):74. PubMed ID: 38383423
[TBL] [Abstract][Full Text] [Related]
19. Next generation DNA sequencing of atypical choroid plexus papilloma of brain: Identification of novel mutations in a female patient by Ion Proton.
Taher MM; Hassan AA; Saeed M; Jastania RA; Nageeti TH; Alkhalidi H; Dairi G; Abduljaleel Z; Athar M; Bouazzaoui A; El-Bjeirami WM; Al-Allaf FA
Oncol Lett; 2019 Nov; 18(5):5063-5076. PubMed ID: 31612017
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
